<div id="readability-page-1"><article>BRISBANE, Calif.--(BUSINESS WIRE)--CareDx, Inc. (Nasdaq: CDNA), — The Transplant Company™ — a leading precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers, today announced the award of inducement grants.On April 30, 2026, as an inducement material to acceptance of employment with CareDx, 23 new employees were awarded restricted stock units (RSUs) for an aggregate of 63,856 shares of common stock.The RSU awards were made pursuant to the Company’s 2019 and 2025 Inducement Equity Incentive Plans in accordance with Nasdaq Listing Rule 5635(c)(4).The RSUs will vest over four years, with 25% of the RSUs vesting on the first anniversary of each employee’s vesting commencement date, and 1/16th of the RSUs vesting on each date that is three (3) months thereafter subject to each employee’s continued service through each vesting date.CareDx is providing this information in accordance with Nasdaq Listing Rule 5635(c)(4).<img src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1hY3FyOCZzdHk9MjAyNjA1MDE4Nzc2MTNyMQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" original-src="https://imageproxy.pbkrs.com/https://cts.businesswire.com/ct/CT/query-ZGlzdHJvPW54JmlkPWJ3bmV3cyZsYW5nPWVuJnNpZD1hY3FyOCZzdHk9MjAyNjA1MDE4Nzc2MTNyMQ"/>View source version on businesswire.com: https://www.businesswire.com/news/home/20260501877613/en/<div>CareDx Media Contacts Natasha Moshirian Wagner nwagner@caredx.comInvestor Relations Caroline Corner investor@caredx.com</div>Source: CareDx, Inc.</article></div>

CDNA

CareDx, Inc. announced the award of inducement grants under Nasdaq Listing Rule 5635(c)(4) for 23 new employees, totaling 63,856 restricted stock units (RSUs). The RSUs will vest over four years, with 25% vesting on the first anniversary and the remainder vesting quarterly thereafter, contingent on continued employment. This announcement aligns with the company's 2019 and 2025 Inducement Equity Incentive Plans.

StockTitan

Caredex

iShares US Healthcare Providers

VanEck Biotech ETF

ALPS Medical Breakthrough

Proshares Ultra Nasdaq Biotech

iShares Biotechnology ETF

SPDR S&P Biotech

Direxion S&P Biotech Bull 3X

Ark Genomic Revolution ETF

Invesco Biotechnology & Genome ETF

Health Care Select Sector SPDR

iShares US Medical Devices

iShares Genomics Immunology and Healthcare ETF

First Trust NYSE Arca Biotech Index Fd

Nasdaq

CareDx Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | CDNA Stock News